Who is sponsoring NCT05593796?

NCT05593796 is sponsored by Assiut University.

What drugs are being tested in NCT05593796?

Interventions in NCT05593796: cognitive behavioral therapy.

What condition does NCT05593796 study?

NCT05593796 studies Methamphetamine Abuse.

Is NCT05593796 still recruiting?

NCT05593796 is currently status unknown. Last updated 14 August 2023.

Last reviewed 2023-08-14 · How we verify

NCT05593796

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

Status unknown NA Last updated 14 August 2023

What this trial tests

NA trial testing cognitive behavioral therapy in Methamphetamine Abuse in 50 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 January 2025

1 March 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	1 September 2023
Primary completion	1 January 2025
Estimated completion	1 March 2025

Drugs / interventions tested

cognitive behavioral therapy

Conditions studied

Methamphetamine Abuse — all drugs for Methamphetamine Abuse →

Sponsor

Assiut University

Who can join

Adults 15 to 50, male only, with Methamphetamine Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Psychosocial interventions for stimulant use disorder.
Minozzi S, Saulle R, Amato L, Traccis F, et al · · 2024 · cited 15× · PMID 38357958 · DOI 10.1002/14651858.cd011866.pub3

Verify or expand the search:

Other trials of cognitive behavioral therapy

Trials testing the same drug.

NCT07281352 — RCT of Psilocybin-assisted CBT for Depression · Phase 1, PHASE2 · recruiting
NCT06208111 — A Clinical Trial of Cognitive Behavior Therapy for Depression, Stigmatization, Excessive Worries, and Emotional Manageme · NA · unknown
NCT06064032 — Cognitive Behavioral Therapy And Motor Learning Technique Among Attention Deficit Hyperactivity Disorder Adults · NA · unknown
NCT06013085 — Effects of Cognitive-behavioral Therapy for Insomnia in Nurses With Post Covid-19 Condition · NA · not yet recruiting
NCT06177262 — Characteristics of Illness Awareness in Anorexia Nervosa · unknown

Other recruiting trials for Methamphetamine Abuse

Currently open trials in the same condition.

NCT06721494 — A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamin · Phase 2 · recruiting
NCT06496750 — Ketamine for Methamphetamine Use Disorder · Phase 2 · recruiting
NCT06410196 — Mood and Decision-making in Methamphetamine Use Disorder · NA · recruiting
NCT06233799 — Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder · Phase 3 · recruiting
NCT05700994 — Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM) · NA · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05593796 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 14 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05593796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing